Purchase of Aton spotlights HDAC inhibitors

Nat Biotechnol. 2004 Apr;22(4):364-5. doi: 10.1038/nbt0404-364.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Biotechnology / methods*
  • Chromatin / metabolism
  • Drug Design
  • Drug Industry / methods*
  • Enzyme Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors*
  • Humans
  • Models, Biological
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents
  • Chromatin
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors